戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              AIMS dyskinesia score was also reduced in the 40 mg/day
2                                              AIMS OF THE STUDY: To compare sociodemographic, clinical
3                                              AIMS was delivered by nurses during routine clinic visit
4                                              AIMS/HYPOTHESIS: We have previously shown the implicatio
5                                              AIMS: Doxorubicin (DOX), a widely used anticancer agent,
6                                              AIMS: The mdx mouse has proven to be useful in understan
7                                              AIMS: The recent and ongoing worldwide expansion in prev
8                                              AIMS: This two phase study aimed to explore health care
9                                              AIMS: To (i) estimate the diagnostic accuracy of ThermoS
10                                              AIMS: To assess in a pilot study whether (i) Allergy Dia
11                                              AIMS: To compare the risk of vascular disease, HbA1c and
12                                              AIMS: To determine the incidence of functional stroke mi
13                                              AIMS: To identify neural network differences in the hemo
14                                              AIMS: To quantify the volume, type and costs, in a Unite
15                                Additionally, AIMS was cost-effective (ie, dominant: cheaper and more
16                               BACKGROUND AND AIMS: Diabetes mellitus is likely to have a major effect
17                               BACKGROUND AND AIMS: Duodenoscopes have been implicated in the transmis
18                               BACKGROUND AND AIMS: Hyperoxaluria after Roux-en-Y gastric bypass (RYGB
19                               BACKGROUND AND AIMS: Immunosuppressive therapy for inflammatory bowel d
20                               BACKGROUND AND AIMS: Proteomics holds promise for individualizing cance
21                               BACKGROUND AND AIMS: The IL28B genotype has been linked to sustained vi
22                               BACKGROUND AND AIMS: The mammalian intestinal epithelium self-renews ra
23                               BACKGROUND AND AIMS: The risk of hepatocellular cancer (HCC) after sust
24                               BACKGROUND AND AIMS: Tumor necrosis factor (TNF) is a cytokine that pro
25                                 BACKGROUND & AIMS: 5-hydroxytryptamine receptor (5-HT(4)R) agonists p
26                                 BACKGROUND & AIMS: A diagnosis of celiac disease is made based on cli
27                                 BACKGROUND & AIMS: A reduction in portal pressure gradient (PPG) to <
28                                 BACKGROUND & AIMS: A system is needed to determine the risk of patien
29                                 BACKGROUND & AIMS: A variety of fecal immunochemical tests (FITs) for
30                                 BACKGROUND & AIMS: Accurate optical analysis of colorectal polyps (op
31                                 BACKGROUND & AIMS: Activating mutations in KRAS are detected in most
32                                 BACKGROUND & AIMS: Administration of tryptophan and some of its metab
33                                 BACKGROUND & AIMS: Adult stem cells have been proposed to be quiescen
34                                 BACKGROUND & AIMS: After careful pilot studies and planning, the nati
35                                 BACKGROUND & AIMS: Agents that induce an immune response against tumo
36                                 BACKGROUND & AIMS: Alagille syndrome is a genetic disorder characteri
37                                 BACKGROUND & AIMS: Algorithms for diagnosis of malignant common bile
38                                 BACKGROUND & AIMS: Almost all colorectal polyps </= 5 mm are benign,
39                                 BACKGROUND & AIMS: Alterations in signaling pathways that regulate re
40                                 BACKGROUND & AIMS: Although interleukin 28B (interferon, lambda 3) (I
41                                 BACKGROUND & AIMS: Although the adenoma detection rate is used as a m
42                                 BACKGROUND & AIMS: Although there is a genetic predisposition to colo
43                                 BACKGROUND & AIMS: Although tumor necrosis factor (TNF) antagonists r
44                                 BACKGROUND & AIMS: Although we are beginning to understand where, whe
45                                 BACKGROUND & AIMS: Among patients with large colorectal sessile polyp
46                                 BACKGROUND & AIMS: Among subjects screened for colorectal cancer (CRC
47                                 BACKGROUND & AIMS: Approximately 10% of children on the liver transpl
48                                 BACKGROUND & AIMS: Approximately 50% of all patients with pancreatic
49                                 BACKGROUND & AIMS: Ascites are the most common complication of cirrho
50                                 BACKGROUND & AIMS: Aspirin reduces the incidence of and mortality fro
51                                 BACKGROUND & AIMS: Autosomal recessive polycystic kidney disease (ARP
52                                 BACKGROUND & AIMS: Basiliximab is a chimeric monoclonal antibody that
53                                 BACKGROUND & AIMS: Cardiovascular disease (CVD) is the leading cause
54                                 BACKGROUND & AIMS: CD4+ T-regulatory (Treg) cells suppress immune res
55                                 BACKGROUND & AIMS: Celiac disease is a chronic small intestinal infla
56                                 BACKGROUND & AIMS: Celiac disease is characterized by HLA-DQ2/8-restr
57                                 BACKGROUND & AIMS: Cell stress signaling pathways result in phosphory
58                                 BACKGROUND & AIMS: Cell therapy offers the potential to treat gastroi
59                                 BACKGROUND & AIMS: Central neuromodulators (antidepressants, antipsyc
60                                 BACKGROUND & AIMS: Central obesity promotes gastroesophageal reflux,
61                                 BACKGROUND & AIMS: Certain subsets of colorectal serrated polyps (SP)
62                                 BACKGROUND & AIMS: Cholangiocarcinomas (CCA) are resistant to chemoth
63                                 BACKGROUND & AIMS: Cholecystectomy (CCY) after an episode of choledoc
64                                 BACKGROUND & AIMS: Cholera toxin can act as a modulator of the immune
65                                 BACKGROUND & AIMS: Chronic hepatitis affects phenotypes of innate and
66                                 BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is a maj
67                                 BACKGROUND & AIMS: Chronic, excessive alcohol consumption leads to al
68                                 BACKGROUND & AIMS: Clinical studies showed teduglutide to increase ur
69                                 BACKGROUND & AIMS: Colorectal cancer (CRC) screening using quantitati
70                                 BACKGROUND & AIMS: Concurrent to development of more effective drugs
71                                 BACKGROUND & AIMS: Consumption of sugar is associated with obesity, t
72                                 BACKGROUND & AIMS: Cytokinesis can fail during normal postnatal liver
73                                 BACKGROUND & AIMS: Daclatasvir is a direct-acting antiviral agent and
74                                 BACKGROUND & AIMS: De novo synthesis of guanosine diphosphate (GDP)-f
75                                 BACKGROUND & AIMS: Depletion of interstitial cells of Cajal (ICCs) is
76                                 BACKGROUND & AIMS: Despite inducing an inflammatory response, Helicob
77                                 BACKGROUND & AIMS: Diagnosis of inflammatory bowel diseases (IBD) is
78                                 BACKGROUND & AIMS: Diarrhea associated with inflammatory bowel diseas
79                                 BACKGROUND & AIMS: Dietary fiber is implicated as a risk factor for d
80                                 BACKGROUND & AIMS: Dietary restriction of fermentable carbohydrates (
81                                 BACKGROUND & AIMS: Direct oral anticoagulant (DOAC) agents increase t
82                                 BACKGROUND & AIMS: Disordered defecation is attributed to pelvic floo
83                                 BACKGROUND & AIMS: Drugs that inhibit the erb-b2 receptor tyrosine ki
84                                 BACKGROUND & AIMS: Dysbiosis of the intestinal microbiota has been as
85                                 BACKGROUND & AIMS: Effective treatments are needed for hepatic steato
86                                 BACKGROUND & AIMS: Elbasvir (an NS5A inhibitor) and grazoprevir (an N
87                                 BACKGROUND & AIMS: Endoscopic ultrasound (EUS)-guided chemoablation w
88                                 BACKGROUND & AIMS: Endoscopists do not routinely follow guidelines to
89                                 BACKGROUND & AIMS: Endoscopy is an integral part of the investigation
90                                 BACKGROUND & AIMS: Epigenetic mechanisms might be involved in the reg
91                                 BACKGROUND & AIMS: Estrogen has been proposed to modulate gut inflamm
92                                 BACKGROUND & AIMS: Excellent single-center outcomes of neoadjuvant ch
93                                 BACKGROUND & AIMS: Fecal microbiota transplantation (FMT) is a highly
94                                 BACKGROUND & AIMS: Feeding during the first months of life might affe
95                                 BACKGROUND & AIMS: Few studies have examined the association between
96                                 BACKGROUND & AIMS: Fibrolamellar hepatocellular carcinoma (FL-HCC) is
97                                 BACKGROUND & AIMS: Foodborne illness affects 15% of the US population
98                                 BACKGROUND & AIMS: For 4 decades, stigmata of recent hemorrhage in pa
99                                 BACKGROUND & AIMS: For patients with Barrett's esophagus, the diagnos
100                                 BACKGROUND & AIMS: Functional constipation (FC) is a common childhood
101                                 BACKGROUND & AIMS: Gastric hypersensitivity (GHS) contributes to epig
102                                 BACKGROUND & AIMS: Gastrointestinal (GI) diseases account for substan
103                                 BACKGROUND & AIMS: Gastroparesis is a complication of diabetes with f
104                                 BACKGROUND & AIMS: GATA3 is a transcription factor that regulates T-c
105                                 BACKGROUND & AIMS: Gluten ingestion leads to symptoms and small intes
106                                 BACKGROUND & AIMS: Healthy eating patterns assessed by diet quality i
107                                 BACKGROUND & AIMS: Helicobacter pylori is remarkable for its genetic
108                                 BACKGROUND & AIMS: Heme oxygenase-1 (HO-1) and its metabolic by-produ
109                                 BACKGROUND & AIMS: Hepatic encephalopathy (HE) is a serious complicat
110                                 BACKGROUND & AIMS: Hepatitis B virus (HBV) infects hepatocytes, but t
111                                 BACKGROUND & AIMS: Hepatitis E virus (HEV) infection is a major cause
112                                 BACKGROUND & AIMS: Hepatocellular adenomas (HCAs) are benign liver tu
113                                 BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a leading cause
114                                 BACKGROUND & AIMS: Heritable factors contribute to the development of
115                                 BACKGROUND & AIMS: Hirschsprung disease is caused by failure of enter
116                                 BACKGROUND & AIMS: Human tumors and liver cancer cell lines express t
117                                 BACKGROUND & AIMS: Immunodeficiency and autoimmune sequelae, includin
118                                 BACKGROUND & AIMS: Improved therapy has substantially increased survi
119                                 BACKGROUND & AIMS: In colorectal tumors, hypoxia causes resistance to
120                                 BACKGROUND & AIMS: In healthy individuals, interactions between intes
121                                 BACKGROUND & AIMS: In most patients with Parkinson's disease, gastroi
122                                 BACKGROUND & AIMS: Individuals with cystic fibrosis are at increased
123                                 BACKGROUND & AIMS: Individuals with cystic fibrosis are at increased
124                                 BACKGROUND & AIMS: Inefficient fatty acid oxidation in mitochondria a
125                                 BACKGROUND & AIMS: Infections are common in patients with severe alco
126                                 BACKGROUND & AIMS: Inflammatory bowel diseases (IBD) increase risk fo
127                                 BACKGROUND & AIMS: Inflammatory bowel diseases (IBDs) increase the ri
128                                 BACKGROUND & AIMS: Inhibitors of the epidermal growth factor receptor
129                                 BACKGROUND & AIMS: Inhibitors of the hepatitis C virus (HCV) NS5A pro
130                                 BACKGROUND & AIMS: Interactions between commensal microbes and the im
131                                 BACKGROUND & AIMS: Interferon-free direct-acting antiviral (DAA) ther
132                                 BACKGROUND & AIMS: Intestinal epithelial homeostasis is maintained by
133                                 BACKGROUND & AIMS: Intraductal papillary mucinous neoplasias (IPMNs)
134                                 BACKGROUND & AIMS: Invariant natural killer T (iNKT) cells undergo ca
135                                 BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is associated with
136                                 BACKGROUND & AIMS: It is a challenge to deliver nucleic acids to gast
137                                 BACKGROUND & AIMS: It is not clear how the complex interactions betwe
138                                 BACKGROUND & AIMS: It might be possible to manipulate the intestinal
139                                 BACKGROUND & AIMS: Knowledge of temporal associations between screen-
140                                 BACKGROUND & AIMS: Ligand binding to inhibitory receptors on immune c
141                                 BACKGROUND & AIMS: Little is known about factors associated with a su
142                                 BACKGROUND & AIMS: Little is known about factors that regulate intest
143                                 BACKGROUND & AIMS: Little is known about provider and health system f
144                                 BACKGROUND & AIMS: Little is known about substitutions that mediate r
145                                 BACKGROUND & AIMS: Little is known about the absolute risk of hepatoc
146                                 BACKGROUND & AIMS: Little is known about the causes of heartburn in p
147                                 BACKGROUND & AIMS: Little is known about the development of branch du
148                                 BACKGROUND & AIMS: Little is known about the incidence of celiac dise
149                                 BACKGROUND & AIMS: Little is known about the prevalence and burden of
150                                 BACKGROUND & AIMS: Little is known about the signaling pathways that
151                                 BACKGROUND & AIMS: Liver cirrhosis is complicated by bleeding from po
152                                 BACKGROUND & AIMS: Liver regeneration after partial hepatectomy (PH)
153                                 BACKGROUND & AIMS: Low activity of natural killer (NK) cells has been
154                                 BACKGROUND & AIMS: Low estrogen levels can contribute to development
155                                 BACKGROUND & AIMS: Macrophages mediate the epithelial response to Hel
156                                 BACKGROUND & AIMS: Magnetic resonance imaging (MRI) techniques and ul
157                                 BACKGROUND & AIMS: Maintenance and differentiation of progenitor cell
158                                 BACKGROUND & AIMS: Many different types of cancer cells have chromoso
159                                 BACKGROUND & AIMS: Many patients with a < 1 cm segment of columnar me
160                                 BACKGROUND & AIMS: Many patients with inflammatory bowel diseases (IB
161                                 BACKGROUND & AIMS: MEDI2070 is a human monoclonal antibody that selec
162                                 BACKGROUND & AIMS: Microparticles released into the bloodstream upon
163                                 BACKGROUND & AIMS: MicroRNAs (miRNAs) can promote or inhibit tumor gr
164                                 BACKGROUND & AIMS: MicroRNAs (miRNAs) have been implicated in the dev
165                                 BACKGROUND & AIMS: Multiple endoscopic bariatric therapies (EBTs) cur
166                                 BACKGROUND & AIMS: Narrow-band imaging is an image-enhanced form of e
167                                 BACKGROUND & AIMS: Neural stem and progenitor cells from the enteric
168                                 BACKGROUND & AIMS: New-onset diabetes in patients with pancreatic can
169                                 BACKGROUND & AIMS: Non-celiac gluten sensitivity is characterized by
170                                 BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is a cons
171                                 BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is associ
172                                 BACKGROUND & AIMS: Nosocomial infections with Clostridium difficile p
173                                 BACKGROUND & AIMS: Obesity-related insulin resistance contributes to
174                                 BACKGROUND & AIMS: Paneth cell dysfunction causes deficiencies in int
175                                 BACKGROUND & AIMS: Paneth cells contribute to the small intestinal ni
176                                 BACKGROUND & AIMS: Patients with acute liver failure (ALF) have defec
177                                 BACKGROUND & AIMS: Patients with acute liver failure (ALF) have high
178                                 BACKGROUND & AIMS: Patients with celiac disease should maintain a glu
179                                 BACKGROUND & AIMS: Patients with chronic hepatitis C virus (HCV) geno
180                                 BACKGROUND & AIMS: Patients with chronic hepatitis C virus (HCV) infe
181                                 BACKGROUND & AIMS: Patients with hepatitis C virus-associated cirrhos
182                                 BACKGROUND & AIMS: Patients with inflammatory liver disease commonly
183                                 BACKGROUND & AIMS: Patients with severe alcoholic hepatitis (AH) have
184                                 BACKGROUND & AIMS: Patients with systemic sclerosis (SSc) have impair
185                                 BACKGROUND & AIMS: People infected with human immunodeficiency virus
186                                 BACKGROUND & AIMS: Pharmacologic treatment of eosinophilic esophagiti
187                                 BACKGROUND & AIMS: Polymorphisms in the IL28B gene have been associat
188                                 BACKGROUND & AIMS: Polymorphisms that reduce the function of nucleoti
189                                 BACKGROUND & AIMS: Poorly digested, fermentable carbohydrates may ind
190                                 BACKGROUND & AIMS: Preclinical studies have shown aspirin to have ant
191                                 BACKGROUND & AIMS: Previous studies have suggested that dietary folic
192                                 BACKGROUND & AIMS: Previous studies reported that black vs white disp
193                                 BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is an orphan
194                                 BACKGROUND & AIMS: Probiotics can reduce symptoms of irritable bowel
195                                 BACKGROUND & AIMS: Progression of liver fibrosis in experimental mode
196                                 BACKGROUND & AIMS: Prostaglandin-endoperoxide synthase (Ptgs)2 is an
197                                 BACKGROUND & AIMS: Proton pump inhibitors (PPI) are among the top 10
198                                 BACKGROUND & AIMS: Proton pump inhibitors (PPI) have been associated
199                                 BACKGROUND & AIMS: Proton pump inhibitors (PPIs) and histamine-2 rece
200                                 BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are commonly used me
201                                 BACKGROUND & AIMS: Radiofrequency ablation (RFA) reduces the risk of
202                                 BACKGROUND & AIMS: Recommendations for surveillance after curative su
203                                 BACKGROUND & AIMS: Relative risk of colorectal cancer (CRC) decreases
204                                 BACKGROUND & AIMS: Resistance of metastatic human colorectal cancer c
205                                 BACKGROUND & AIMS: Roux-en-Y gastric bypass (RYGB) improves glucose h
206                                 BACKGROUND & AIMS: Screening decreases colorectal cancer (CRC) incide
207                                 BACKGROUND & AIMS: Separation of newborn rats from their mothers indu
208                                 BACKGROUND & AIMS: Signaling lymphocyte activation molecule (Slamf)1
209                                 BACKGROUND & AIMS: Smoking, an independent risk factor for pancreatit
210                                 BACKGROUND & AIMS: Statin use has been associated with a reduced inci
211                                 BACKGROUND & AIMS: Stimulation of nucleotide-binding oligomerization
212                                 BACKGROUND & AIMS: Studies have reported associations between proton
213                                 BACKGROUND & AIMS: Studies of Clostridium difficile infections (CDIs)
214                                 BACKGROUND & AIMS: Studies of the pressure response of the upper esop
215                                 BACKGROUND & AIMS: Surveillance guidelines for serrated polyps (SPs)
216                                 BACKGROUND & AIMS: Surveillance of patients with cirrhosis increases
217                                 BACKGROUND & AIMS: Survival times vary among patients with neuroendoc
218                                 BACKGROUND & AIMS: Systematic reviews have provided evidence for the
219                                 BACKGROUND & AIMS: T cells are an important component for development
220                                 BACKGROUND & AIMS: Tests to measure serum endomysial antibodies (EMA)
221                                 BACKGROUND & AIMS: The association between prevalence of celiac disea
222                                 BACKGROUND & AIMS: The canonical Wnt signaling pathway activates the
223                                 BACKGROUND & AIMS: The clinical course of chronic pancreatitis is unp
224                                 BACKGROUND & AIMS: The efficacy of abatacept, a selective costimulati
225                                 BACKGROUND & AIMS: The enteric abundance of serotonin (5-HT), its abi
226                                 BACKGROUND & AIMS: The enteric nervous system (ENS) regulates gastroi
227                                 BACKGROUND & AIMS: The goal of treatment for Barrett's esophagus (BE)
228                                 BACKGROUND & AIMS: The guidelines of the European Society of Pediatri
229                                 BACKGROUND & AIMS: The gut microbiota affects host lipid and glucose
230                                 BACKGROUND & AIMS: The IMAgINE 1 study (NCT00409682) evaluated the sa
231                                 BACKGROUND & AIMS: The incidence and mortality of hepatocellular carc
232                                 BACKGROUND & AIMS: The incidence of colorectal cancer (CRC) in indivi
233                                 BACKGROUND & AIMS: The increase in use of anesthesia assistance (AA)
234                                 BACKGROUND & AIMS: The inflammatory bowel diseases (IBD) ulcerative c
235                                 BACKGROUND & AIMS: The innate immune system responds not only to bact
236                                 BACKGROUND & AIMS: The mitochondrial nicotinamide adenine dinucleotid
237                                 BACKGROUND & AIMS: The multiple endocrine neoplasia, type 1 (MEN1) lo
238                                 BACKGROUND & AIMS: The nuclear receptor subfamily 1 group H member 4
239                                 BACKGROUND & AIMS: The pathogenesis of cirrhosis, a disabling outcome
240                                 BACKGROUND & AIMS: The pathogenesis of liver fibrosis involves activa
241                                 BACKGROUND & AIMS: The purpose of this review is to evaluate the risk
242                                 BACKGROUND & AIMS: The quality of endoscopists' colonoscopy performan
243                                 BACKGROUND & AIMS: The role of sphincter of Oddi manometry (SOM) in t
244                                 BACKGROUND & AIMS: The role of the intestine in the maintenance of ch
245                                 BACKGROUND & AIMS: The role of tobacco smoke in the etiology of infla
246                                 BACKGROUND & AIMS: The signaling molecule and transcriptional regulat
247                                 BACKGROUND & AIMS: The type III interferons (IFN-lambdas: interleukin
248                                 BACKGROUND & AIMS: Therapies for perianal fistulas in patients with C
249                                 BACKGROUND & AIMS: There are few effective treatments for nausea and
250                                 BACKGROUND & AIMS: There is controversy over the ability of transjugu
251                                 BACKGROUND & AIMS: There is controversy regarding the role of the typ
252                                 BACKGROUND & AIMS: There is growing interest in the use of bone marro
253                                 BACKGROUND & AIMS: There is suboptimal inter-observer agreement, even
254                                 BACKGROUND & AIMS: Tumor necrosis factor (TNF) is an inflammatory cyt
255                                 BACKGROUND & AIMS: Tumor-suppressor proteins are inactivated by many
256                                 BACKGROUND & AIMS: Use of aspirin and/or non-aspirin nonsteroidal ant
257                                 BACKGROUND & AIMS: Use of monitored anesthesia care (MAC) for gastroi
258                                 BACKGROUND & AIMS: Variants in the tumor necrosis factor superfamily
259                                 BACKGROUND & AIMS: Video capsule endoscopy (CE) provides a noninvasiv
260                                 BACKGROUND & AIMS: Visceral hypersensitivity is one feature of irrita
261                                 BACKGROUND & AIMS: We analyzed DNA methylation patterns and transcrip
262                                 BACKGROUND & AIMS: We assessed the diagnostic performance of magnetic
263                                 BACKGROUND & AIMS: We developed comprehensive models to determine ris
264                                 BACKGROUND & AIMS: We have limited knowledge about the association be
265                                 BACKGROUND & AIMS: We investigated the rate and predictors of anesthe
266                                 BACKGROUND & AIMS: We investigated the roles of interleukin 28A (also
267                                 BACKGROUND & AIMS: We investigated whether antioxidant therapy reduce
268                                 BACKGROUND & AIMS: We investigated whether patients with multiple ser
269                                 BACKGROUND & AIMS: We performed a prospective study to investigate th
270                                 BACKGROUND & AIMS: Western and prudent dietary patterns have been ass
271                                 BACKGROUND & AIMS: Wheat amylase-trypsin inhibitors (ATIs) are nutrit
272                                 BACKGROUND & AIMS: When the glial fibrillary acidic protein (GFAP) pr
273                                 BACKGROUND & AIMS: Wilson disease is a disorder of copper (Cu) misbal
274                                 BACKGROUND & AIMS: Zinc homeostasis in cells is maintained through ti
275                                  BACKGROUND& AIMS: Proton pump inhibitors and nonsteroidal anti-infla
276                                BACKGROUND, & AIMS: Studies of primary biliary cirrhosis (PBC) phenoty
277                                   BACKGROUND/AIMS: Chronic kidney disease (CKD) is an important comor
278                                   BACKGROUND/AIMS: Depression is associated with an increased risk fo
279                                   BACKGROUND/AIMS: Patients with vestibular disease have been observe
280                                   BACKGROUND/AIMS: The aim of the present study is to probe the poten
281 fied intention-to-treat population (baseline AIMS score >/=6 and at least one post-baseline rating).
282  (items 1-7), as assessed by blinded central AIMS video raters.
283 ndomly assigned participants (1:1) to either AIMS or treatment as usual (ie, containing a range of co
284 uares mean change from baseline to week 6 in AIMS dyskinesia score was -3.2 for the 80 mg/day group,
285  baseline to week 12, the least-squares mean AIMS score improved by -3.3 points (SE 0.42) in the deut
286                            Implementation of AIMS in routine clinical HIV care is therefore recommend
287                 Moreover, the improvement of AIMS total score correlated with the increase in BDNF le
288 ning sessions of 6 h each (18 h in total) on AIMS and a 1.5 h booster training session at the clinic
289 Motor function [Alberta Infants Motor Scale (AIMS)] and clinical symptoms (parental questionnaire) we
290  on the Abnormal Involuntary Movement Scale (AIMS) dyskinesia score (items 1-7), as assessed by blind
291 ange in Abnormal Involuntary Movement Scale (AIMS) score from baseline to week 12 in patients with at
292 idated by Accurate Inclusion Mass Screening (AIMS) and immunostaining and supported for the retinal g
293 dherence Improving self-Management Strategy (AIMS) compared with treatment as usual.
294                               In this study, AIMS reduced viral load, increased QALYs, and saved reso
295 ngs from preparatory studies have shown that AIMS is acceptable, feasible to deliver in routine care,
296 opies per mL [95% CI 35.5-55.9]) than in the AIMS group (estimated marginal mean 35.4 copies per mL [
297              Furthermore, improvement in the AIMS score was greatest in those with the Val/Val allele
298             The median (IQR) increase in the AIMS score was higher in the cobalamin group than in the
299 mple comprised 221 patients; 109 assigned to AIMS and 112 to treatment as usual.
300 nt Instrument for Mental Health Systems (WHO-AIMS) were included in multiple regression analyses to i

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top